| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |